Total Cycles
818
Reported 2022
Medical Disclaimer: This data is for informational purposes only. Success rates are influenced by patient age, diagnosis, and treatment type. Do not use this data alone to choose a fertility clinic. Consult a board-certified reproductive endocrinologist.
Aspire Fertility-Dallas reported a 32.0% overall live-birth rate across 818 ART cycles in Addison, Texas (CDC NASS 2022).
Aspire Fertility-Dallas, located in Addison, Texas, reports an overall IVF success rate of 32.0% across 818 reported cycles (CDC NASS 2022). Patients under 35 see a success rate of 42.1%. Age-group breakdowns and historical trends are below.
Total Cycles
818
Reported 2022
Overall Success Rate
32.0%
Live births per cycle
-3.4pp vs TX avg
Rate Under 35
42.1%
Peak fertility cohort
Single Embryo Transfer
38.9%
ASRM-aligned safety metric
Single-embryo-transfer rate is an ASRM-aligned safety metric — higher SET reduces multi-pregnancy and OHSS risk.
Share of transfers using one embryo only
Using own eggs (fresh + frozen cycles). CDC reports patients over 40 as a single group.
Success rate = live births per ART cycle started. Source: CDC NASS 2022.
Aspire Fertility-Dallas reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 818 total ART cycles, split between 25 fresh and 793 frozen embryo transfer cycles. The overall success rate — live births per cycle started — was 32.0%. That is 3.4 percentage points below the Texas state average of 35.4%, which may reflect a more complex patient case mix rather than quality of care.
Age remains the dominant variable in IVF outcomes. At Aspire Fertility-Dallas, patients under 35 saw a 42.1% success rate, compared with 29.7% for ages 35–37 and 30.9% for ages 38–40. The over-40 cohort reported 7.1%. Single embryo transfer (SET) was used in 38.9% of cycles, a metric ASRM associates with lower multi-pregnancy rates.
Service availability also affects which clinics fit which patients. Aspire Fertility-Dallas does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary — PlainFertility is not affiliated with Aspire Fertility-Dallas or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.
Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer — a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.
| Year | Total Cycles | Overall | Under 35 | 35–37 | 38–40 | Over 40 |
|---|---|---|---|---|---|---|
| 2022 | 818 | 32.0% | 42.1% | 29.7% | 30.9% | 7.1% |
| 2021 | 630 | 36.2% | 50.4% | 31.7% | 17.9% | 11.1% |
| 2020 | 461 | N/A | N/A | N/A | N/A | N/A |
Aspire Fertility-Dallas reports an overall IVF success rate of 32.0% across 818 reported cycles. Rates by age group vary — patients under 35 generally see higher success rates.
IVF success rates depend on patient age, diagnosis, embryo type, and treatment protocol. A clinic with a lower success rate may treat more complex cases. Always consult a board-certified reproductive endocrinologist who can evaluate your individual situation.
All data is sourced from the CDC's National ART Surveillance System (NASS), which requires all ART clinics in the US to report their cycle outcomes annually under the Fertility Clinic Success Rate and Certification Act of 1992.
Fresh cycles use embryos that have not been frozen — eggs are retrieved, fertilized, and transferred within the same treatment cycle. Frozen cycles use previously cryopreserved embryos. Aspire Fertility-Dallas reported 25 fresh cycles and 793 frozen cycles. Many clinics now favor frozen embryo transfers (FET) due to improved vitrification technology and comparable or higher success rates.
Single embryo transfer percentage indicates how often a clinic transfers just one embryo per cycle rather than multiple embryos. A higher SET rate generally reflects adherence to current ASRM guidelines aimed at reducing multiple pregnancies. Aspire Fertility-Dallas reports a SET rate of 38.9%. Higher SET rates typically mean fewer twins and triplets, which reduces pregnancy complications.
Aspire Fertility-Dallas does offer donor egg services and does offer gestational carrier (surrogate) services per the latest CDC NASS report. Contact the clinic directly to confirm current service availability and discuss whether these options are appropriate for your treatment plan.
Data source: CDC National ART Surveillance System (NASS). PlainFertility is not affiliated with the CDC or this clinic.
Read our methodology — how this data is sourced, computed, and verified.